Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Mason Barge who wrote (254)	11/12/1998 7:04:00 PM
From: technetx	Read Replies (1) \| Respond to of 422

Mason, Tom is right on track. It will take brokerage houses and institutions to raise the share price. We need the analysts' attention. Very few individuals can recognize Blud's prospects, in spite of the present news. Most persons are not "number crunchers. " They need to be led. They need assurances by the "people in the know", and they need to be called by their broker and told "buy this one" and here's why. Then they believe. I believe the wheels are turning at this very moment in analysts' offices on the Street. Sequence of events: get their valued clients in first; recommend to the firm to go public with the recommendation; get firm approval; write and publish recommendation report, etc...it takes time; for us,the machine seems to grind slowly, but it grinds steadily, and , most often, thoroughly. Unfortunately, Immucor's products, new and old, are not easily understood, even relative to internet products and services. So, we don't get the EBAY or AMAZON effect. We have to earn our money. But, it has started to be "spoon fed" to the Street, starting with today's press release. When earnings are published, I believe, a feeding frenzy will ensue. From my lips to God's ears, Dominic

To: Mason Barge who wrote (254)	12/16/1998 8:08:00 PM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Earnings Countdown - 3 Weeks Plus Hello Mason, Immucor should release earnings within the next three (3) weeks and four (4) days if my calculations are correct. The suspense is killing me! Regards, Tom

To: Mason Barge who wrote (254)	1/5/1999 5:53:00 PM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Twelve Month Stock Price Target IMHO - Immucor will attain a (TTM) Trailing Twelve Months EPS of $0.50-$0.75 by December '99/January '00 which will result in a stock target price of $15.50 - $23.25 at the current pe of 31. Of course some irrational exuberance could push the stock price higher as momentum investors jump on board and analysts initiate coverage with buy recommendations. Stock Price Formula - PE x EPS = Stock Price The above projections and stock price target are based on prevailing and accepted valuation methods in use today by some of the top analysts. I encourage investors to conduct independent due-diligence and make their own investment decision. Regards, Tom